期刊
PHARMACEUTICS
卷 14, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics14081692
关键词
Cu(II) complex; structure; ROS; cytotoxicity; melanoma cells; bioinformatics; ADME-Tox
资金
- CNCS-UEFISCDI within PNCD III [PN-III-P1-1.1TE-2019-1345]
- Slovenian Research Agency ARRS [P1-0134]
The study investigated copper complexes Cu(N-N)(bzac)(X)center dot nH(2)O, and found that the complexes containing 1,10-phenanthroline exhibited anti-melanoma activity and had favorable drug-likeness and ADME properties. These complexes also showed potential as targets for antitumor molecules and could be promising for melanoma alternative treatment.
Melanoma is a skin cancer characterized by rapid growth and spread for which current therapies produce both resistance and increased risk of infection. To develop new anti-melanoma biocompatible species, the series of complexes Cu(N-N)(bzac)(X)center dot nH(2)O (N-N: 1,10-phenanthroline/2,2 '-bipyridine, Hbzac: 1-phenyl-1,3-butanedione, X: NO3/ClO4, and n = 0, 1) was studied. Single-crystal X-ray diffraction revealed a mononuclear structure for all complexes. The ability of the complexes to scavenge or trap reactive oxygen species such as O-2 center dot(-) and HO center dot was proved by EPR spectroscopy experiments. All complexes inhibited B16 murine melanoma cells in a dose-dependent and nanomolar range, but the complexes with 1,10-phenanthroline were more active. Moreover, comparative activity on B16 and healthy BJ cells revealed a therapeutic index of 1.27-2.24. Bioinformatic methods were used to calculate the drug-likeness, pharmacokinetic, pharmacogenomic, and pharmacodynamic profiles of the compounds. The results showed that all compounds exhibit drug-likeness features, as well as promising absorption, distribution, metabolism, and excretion (ADME) properties, and no toxicity. The pharmacodynamics results showed that the neutral species appear to be good candidates for antitumor molecular targets (Tyrosyl-DNA phosphodiesterase 1, DNA-(apurinic or apyrimidinic site) lyase or Kruppel-like factor 5). Furthermore, the pharmacogenomic results showed a good affinity of the copper(II) complexes for the human cytochrome. These results recommend complexes bearing 1,10-phenanthroline as good candidates for developing drugs to melanoma alternative treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据